Founded in 1966, Dako is one of the world s leading companies in tissue-based cancer diagnostics. The company develops, manufactures and markets cell-based cancer diagnostics for clinical diagnostics and research use. It serves a variety of hospital and research laboratories. Dako offers pathology products, including reagents and antibodies and staining instruments and instruments for image analysis. The company also provides flow cytometry products, instruments for flow cytometry, as well as systems to analyze cells in blood and other fluids. It offers antibodies that are used to measure the concentration of protein in blood, urine and cerebrospinal fluid. Dako additionally manufactures and sells antibody-based products within the area of specific proteins and immunoassays for turbidimetry. The company employs more than 1,000 people and operates in over 70 countries. It has partnerships with universities, companies and organizations within the field of cancer research and diagnostics. Dako is owned by a private equity fund, EQT.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.